<?xml version="1.0" encoding="UTF-8"?>
<p>COVID-19 may affect the cardiovascular (CV) system directly or can exacerbate pre-existing cardiovascular diseases (CVD). Patients with CVD are at a higher risk of adverse events.
 <sup>
  <xref rid="bibr3" ref-type="bibr">3</xref>-
  <xref rid="bibr5" ref-type="bibr">5</xref>
 </sup> The prevalence of CVD in COVID-19 was studied in a meta-analysis of 1527 patients;
 <sup>
  <xref rid="bibr3" ref-type="bibr">3</xref>
 </sup> the study showed that 17.1% had hypertension, 16.4% had CVD, and 9.7% had diabetes. Four studies showed a wide range of CV diseases due to COVID-19 infection, including myocarditis (7-17%), coronary artery disease (5.8%) heart failure (23%), cardiac arrhythmias (16.7%), and cardiogenic shock.
 <sup>
  <xref rid="bibr1" ref-type="bibr">1</xref>,
  <xref rid="bibr5" ref-type="bibr">5</xref>-
  <xref rid="bibr7" ref-type="bibr">7</xref>
 </sup>
</p>
